Stifel on Livanova (LIVN): 'Positive News as OSPREY OSA Trial Hits Early Stop Criteria'
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $65.00 price target on Livanova (NASDAQ: LIVN).The analyst comments "This morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
